New Edge Advisors, LLC Pharming Group N.V. Transaction History
New Edge Advisors, LLC
- $20.5 Billion
- Q3 2025
A detailed history of New Edge Advisors, LLC transactions in Pharming Group N.V. stock. As of the latest transaction made, New Edge Advisors, LLC holds 253 shares of PHAR stock, worth $4,252. This represents 0.0% of its overall portfolio holdings.
Number of Shares
253Holding current value
$4,252% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PHAR
# of Institutions
8Shares Held
78.9KCall Options Held
0Put Options Held
0-
Silverberg Bernstein Capital Management LLC Armonk, NY52.1KShares$876,5910.46% of portfolio
-
Cowen Prime Advisors LLC22.5KShares$377,5520.09% of portfolio
-
Morgan Stanley New York, NY4.36KShares$73,2070.0% of portfolio
-
Ever Source Wealth Advisors, LLC1.38KShares$23,1470.0% of portfolio
-
Global Retirement Partners, LLC23Shares$3860.0% of portfolio
About Pharming Group N.V.
- Ticker PHAR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,241,400
- Market Cap $1.1B
- Description
- Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the tre...